Vévodová Jitka, Graham Ross M, Raux Evelyne, Schubert Heidi L, Roper David I, Brindley Amanda A, Ian Scott A, Roessner Charles A, Stamford N Patrick J, Elizabeth Stroupe M, Getzoff Elizabeth D, Warren Martin J, Wilson Keith S
Structural Biology Laboratory, Department of Chemistry, University of York, Heslington, York YO10 5YW, UK.
J Mol Biol. 2004 Nov 19;344(2):419-33. doi: 10.1016/j.jmb.2004.09.020.
The crystallographic structure of the Pseudomonas denitrificans S-adenosyl-L-methionine-dependent uroporphyrinogen III methyltransferase (SUMT), which is encoded by the cobA gene, has been solved by molecular replacement to 2.7A resolution. SUMT is a branchpoint enzyme that plays a key role in the biosynthesis of modified tetrapyrroles by controlling flux to compounds such as vitamin B(12) and sirohaem, and catalysing the transformation of uroporphyrinogen III into precorrin-2. The overall topology of the enzyme is similar to that of the SUMT module of sirohaem synthase (CysG) and the cobalt-precorrin-4 methyltransferase CbiF and, as with the latter structures, SUMT has the product S-adenosyl-L-homocysteine bound in the crystal. The roles of a number of residues within the SUMT structure are discussed with respect to their conservation either across the broader family of cobalamin biosynthetic methyltransferases or within the sub-group of SUMT members. The D47N, L49A, F106A, T130A, Y183A and M184A variants of SUMT were generated by mutagenesis of the cobA gene, and tested for SAM binding and enzymatic activity. Of these variants, only D47N and L49A bound the co-substrate S-adenosyl-L-methionine. Consequently, all the mutants were severely restricted in their capacity to synthesise precorrin-2, although both the D47N and L49A variants produced significant quantities of precorrin-1, the monomethylated derivative of uroporphyrinogen III. The activity of these variants is interpreted with respect to the structure of the enzyme.
由cobA基因编码的反硝化假单胞菌S-腺苷-L-甲硫氨酸依赖性尿卟啉原III甲基转移酶(SUMT)的晶体结构已通过分子置换法解析至2.7埃分辨率。SUMT是一种分支点酶,通过控制流向维生素B12和西罗血红素等化合物的通量,并催化尿卟啉原III转化为预钴胺素-2,在修饰四吡咯的生物合成中起关键作用。该酶的整体拓扑结构与西罗血红素合酶(CysG)的SUMT模块和钴-预钴胺素-4甲基转移酶CbiF相似,并且与后两者结构一样,SUMT在晶体中结合了产物S-腺苷-L-高半胱氨酸。讨论了SUMT结构中一些残基在钴胺素生物合成甲基转移酶更广泛家族中或SUMT成员亚组内的保守性方面的作用。通过对cobA基因进行诱变产生了SUMT的D47N、L49A、F106A、T130A、Y183A和M184A变体,并测试了它们对SAM的结合和酶活性。在这些变体中,只有D47N和L49A结合了辅底物S-腺苷-L-甲硫氨酸。因此,所有突变体合成预钴胺素-2的能力都受到严重限制,尽管D47N和L49A变体都产生了大量的预钴胺素-1,即尿卟啉原III的单甲基化衍生物。根据酶的结构对这些变体的活性进行了解释。